Gustave Roussy

The Institute Gustave-Roussy (IGR), the leading European anticancer centre, has 2,500 men and women whose missions are to treat patients suffering from cancer, conduct research and develop new therapies, and to pass on knowledge and know-how to the medical and scientific communities in France and world-wide. In terms of research, 400 research scientists conduct projects under the oversight of a scientific council, a therapeutic trials commission and a clinical research committee. In terms of teaching, over 5,000 hours of instruction are taught in its School of Oncology in collaboration with the University of Paris. Each of these three missions is founded on principles that are the guiding force behind IGR's actions daily: * the excellence principle, through which efforts are united to establish quality standards in oncology; * the innovation principle, that is urgently needed for many cancers that are still incurable; * the evaluation principle, without which it is impossible to advance in a rigorous and methodical manner along the path to new therapies. In terms of treatment, IGR is a 400-bed hospital with 124 statutory physicians. Annually over 11,000 new patients are recruited, 130,000 patients attend its clinics and 42,000 patients receive treatment. IGR was accepted as full UICC member in 1983.